Builds on momentum following appointment of CEO and completion of Phase III clinical trials for PlasmaCap IG (Intravenous Immunoglobulin or “IVIG”) MISSISSAUGA, Ontario--(BUSINESS WIRE)--Evolve ...
“Modernizing technology to keep up with evolving business needs can often be a complex proposition. But our Evolve Award winners demonstrate that digital transformation doesn’t need to be complicated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results